Nanox (NASDAQ: NNOX) announced that its subsidiary, Nanox AI Ltd., has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-powered bone health solution, HealthOST, in Italy. The agreement is intended to expand Nanox AI's commercial presence in the Italian market by leveraging Technologic's experience and local market knowledge, according to the announcement covered by NEWMEDIAWIRE.
HealthOST analyzes eligible routine CT scans to provide qualitative and quantitative assessments of the spine, helping clinicians identify patients who may benefit from further evaluation for musculoskeletal conditions such as osteoporosis. The solution is part of the Nanox (NASDAQ: NNOX) ecosystem, which combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.
The distribution agreement matters because osteoporosis is often undiagnosed until a fracture occurs, and routine CT scans performed for other reasons may contain valuable information about bone health that is not typically assessed. By applying AI to these existing scans, HealthOST aims to flag patients who may need further evaluation without requiring additional imaging or radiation exposure. For clinicians in Italy, this could mean an opportunity to integrate bone health assessment into existing workflows, potentially leading to earlier interventions and better management of musculoskeletal conditions.
For the broader healthcare industry, the deal signals continued growth in AI-powered diagnostic tools that extract additional value from routine imaging. As healthcare systems face pressure to improve efficiency and outcomes while managing costs, solutions that repurpose existing data may offer a practical path to preventive care. Nanox's vision is to drive the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform, and this agreement represents a step toward expanding that vision into the Italian market.
Nanox's ecosystem includes Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines healthcare IT expertise with technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions.
For readers and investors, the announcement highlights Nanox's ongoing efforts to commercialize its AI solutions internationally. The company's ability to execute on distribution partnerships will be a key factor in realizing its preventive health vision. As with any forward-looking statement, actual results may differ materially due to risks and uncertainties, including those discussed in the company's SEC filings. To view the full press release, visit https://ibn.fm/y9Zro. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX.
